• March 21, 2017
    PARSIPPANY, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) will participate in the Jefferies Animal Health Summit on Thursday, March 30, 2017, in New York, N.Y. Juan Ramón Alaix, Chief Executive Officer, will represent the company and respond to questions from analysts. He is scheduled to present at 9:30 a.m. ET. The presentation is not scheduled to be webcast. Investors and other interested parties will be able to access the presentation materials at http://investor.more...
  • February 17, 2017
    PARSIPPANY, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) will participate in the Cowen and Company 37th Annual Health Care Conference on March 6, 2017, in Boston, Mass. Clint Lewis, Executive Vice President and President, International Operations at Zoetis, will represent the company and respond to questions from analysts. He is scheduled to present at 4:00 p.m. ET. Investors and other interested parties will be able to access a live audio webcast of themore...
  • February 16, 2017
    PARSIPPANY, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) today reported its financial results for the fourth quarter and full year 2016 and updated its guidance for the full year 2017. The company reported revenue of $1.3 billion for the fourth quarter of 2016, which was flat compared with the fourth quarter of 2015. Net income for the fourth quarter of 2016 was $154 million, or $0.31 per diluted share compared with $22 million and $0.04 per diluted share inmore...
  • February 15, 2017
    PARSIPPANY, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) today announced that the European Commission has granted the company a license for Stronghold® Plus (selamectin/sarolaner), a topical combination of parasiticides that treats ticks, fleas, ear mites, lice and gastrointestinal nematodes and prevents heartworm disease in cats. Veterinarians across the European Union now have a treatment choice that leverages the benefits of sarolaner, a new innovation inmore...
  • February 14, 2017
    PARSIPPANY, N.J.--(BUSINESS WIRE)--The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a second quarter 2017 dividend payable to holders of the company’s common stock of $0.105 per share. The dividend is to be paid on Thursday, June 1, 2017, to holders of record on Thursday, April 6, 2017. About Zoetis Zoetis is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 60 years ofmore...